Skip to content

OsteoDetect

by Imagen Technologies, Inc.

De Novo DEN180005

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 10 Nov 2026

Documents

Trust

Unverified

Source FDA De Novo, synced 10 Nov 2026.

Regulatory status

as of registry sync 10 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN180005 Date24 May 2018DecidedStatusActive

Official records

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA product code
QBS
Device class
Class II
Regulation
21 CFR Part 892.2090
Advisory committee
Radiology
FDA decision
DENG De Novo granted

Overview

AI-generated summary, 10 Nov 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

OsteoDetect is a radiological computer assisted detection/diagnosis software for fracture, as listed by the FDA under the product name Radiological Computer Assisted Detection/Diagnosis Software For Fracture. It was authorized under the De Novo grant DEN180005, which was decided on 2018-05-24.

Similar devices

Other devices filed under FDA product code QBS (Radiological Computer Assisted Detection/Diagnosis Software For Fracture).

Other devices from Imagen Technologies, Inc.

  • ChestSuite 1.0.0

    Class II
  • Chest-CAD 1.0.0

    Class II
  • FractureDetect (FX) 1.0.0

    Class II
  • Aorta-CAD

    Class II

See all devices from Imagen Technologies, Inc. →